glp-1 gip dual agonist GLP-1/GIP | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) Understand GLP-1/GIP Dual Agonist Tirzepatide

Research shows patients typically regain 50-80% of lost weight within 6-12 months after discontinuing treatment

6 Consider choosing protein sources that are low in fat

[12] FEHB Plans: Zepbound on 2026 Formulary Kaiser FEHB and PSHB plans confirm Zepbound on 2026 formularies at Tier 3/4 (specialty tier)

Its not just about warding off that late-night snack attack (though it claims to help with that too)

Careful adjudication of suspected cases was necessary to scrutinize details of the symptomatic presentation, the degree of elevation on pancreatic enzymes, and the diagnostic specificity of imaging data (68)

The one clinical trial that has been completed found that exenatide had no impact on cocaine use or subjective euphoria after using cocaine (Angarita G et al, Drug Alcohol Depend 2021;221:108614)